“Boobs are just the beginning. “That’s how a national magazine led off an article about the miracle of regenerative medicine. “But it’s not just boobs…” I’ve been seeing lots of questions about an ad that starts with those words, complete with visual aids from Steve Christ in a pitch for his The Wealth Advisory newsletter. […]
Articles
- Most Relevant
- Most Recent
From Agora: Promise of Magic Money MachineWhat on earth is this about? In return for your subscription money a fellow who is disgruntled with Wall Street and the hedge fund world gives you nine magic digits and then the company involved has to pay you money. For what pray tell, Doc Gumshoe and the gang of gallant irregulars? By punching in […]
[Ed. Note: Dr. KSS is our biotech and medical maven, who writes for the Irregulars. He has agreed to our trading restrictions, chooses is own topics, and his words and opinions are his own. You can find all of his previous articles and most recent comments on his Stock Gumshoe page.] Although the drive to […]
Alpha Contracts! That’s what’s being teased by the Agora Financial folks these days, all as part of a pitch for Zachary Scheidt’s Contract Income Alert. We haven’t covered this particular letter before, but have covered a few income-oriented pitches by Zach Scheidt for his other letters over the years, mostly talking up dividend-paying stocks and […]
Andy Obermueller writes the Game-Changing Stocks newsletter for StreetAuthority, which is either new or renamed as far as I can tell (it looks like it might have replaced his Government-Driven Investing), and he’s been teasing us with a spiel about the hottest investment opportunities for next year — hoping to get on early, I guess, […]
[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Gumshoe Irregulars. He has agreed to our trading restrictions, he chooses his own topics, and his words and opinions are his own. Enjoy!] OK, admit it….how many of you have seen the campy films of Baltimore director John Waters? The ones starring the […]
Buy this ‘Under $0.50’ Stock by November 1st, 2013 “This is one of the few times in the history of our business we have recommended a company so small and with such high upside potential. A triple-digit gain within the next 12-36 months is highly possible…. “We’ve been vetting the opportunity for nearly two years.” […]
I was going to hold off on writing about this teaser until Friday and cover it just for the Irregulars in the Friday File because it’s a tiny stock and I’ll very likely be influencing the price by writing about it for this larger group today — but I’ve gotten so many questions in just […]
Ah, a good old promise of biotech riches — I haven’t dug into one of these in ages, nothing beats the wild biotech stocks that can see their share price climb 200% (or fall 90%) on a single bit of news. This tease is from Marc Lichtenfeld, whose biotech stuff we’ve looked at several times […]
Patrick Cox is not a shy guy. I don’t think I’ve ever read one of his biotech teaser ads that didn’t leave me convinced (at least for a moment) that the world was about to be changed because of the newest potion or pill that his favorite little companies were developing. And this latest one […]
We’ve got a little teaser stock that has been teased before to briefly share with you, and earlier today I posted an updated look at a Dan Ferris teaser for Altius (again), but I do have a couple other quick notes to get to first. First is that while I was noodling around and looking […]
This teaser ad that I started seeing about ten days ago has both promise for the families of Alzheimer’s sufferers and, of course, the promise of riches for those who get in early on the next hot biotech with a cure for Alzheimer’s Disease. The ad is from Brian Hicks, for a new letter that […]
We’ve got a good teaser to solve today, but first — a quick plea: This will be our final week of “Gumshoe Gives Back” this year — we will be donating at least half of all the membership contributions received through the rest of this week (until the end of the day on Friday, 12/12) […]
On this bright and cheerful Monday we’re taking a look-see at a new entrant in the newsletter world — not only because it teases a couple intriguing investment ideas and promises great gains, as they all do, but because this is the first newsletter I’ve seen that is completely focused on India. Newsletters that look […]
Let’s start with a little exercise… this is the pivotal sentiment of the latest pitch from Chris Wood in his ad for Casey’s Extraordinary Technology newsletter: “The Stock Story I’m About To Share With You Is The BIGGEST Of My Entire Career” How often, do you imagine, is something similar said in an ad for […]
I’ve got a big ol’ pile of updates and thoughts about a dozen or so companies to get to, but we’re going to start with a teaser solution today. Paul Mampilly of Agora Financial’s FDA Trader apparently sent around a teaser note to his own subscribers (I say “apparently” because I’ve only seen the cut-and-paste […]
[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. His words and opinions are his own. Enjoy!] In the Saturday morning Looney Tunes many of us saw as children, one trope always stuck with me: that of the grand piano falling from way up high and crashing, splintering itself. There’s a […]
This teaser has gotten a lot of attention from my readers, as do all the pitches thrown by the folks at Stansberry’s Phase 1 Investor newsletter — you just know that if you charge $5,000 for a subscription, and use one of the world’s largest investor mailing lists to tease a tiny stock in order […]
Exponential Tech Investor is a relatively new newsletter service from the Bonner & Partners stable, but that Bonner/Agora connection means it’s getting a lot of play — and we’ve seen a lot of questions about this latest pitch for the service that hints at a “Tiny Device” that editor Jeff Brown says is “Changing the […]
A version of this story first appeared on January 22, when we first saw Christian DeHaemer’s ad. The ad has been very lightly updated in recent months and is being heavily promoted now, so I’ve gone through and updated this article and my thinking to reflect the coronavirus collapse and any updates the companies have […]
When we’re trying to fight against an adversary that is as strong and full of tricks as cancer, what we need to do is look for points of vulnerability – Achilles heels. We all remember, of course, that the mother of Achilles dipped him in the River Styx when he was a tiny boy, […]
Alpha Contracts! That’s what’s being teased by the Agora Financial folks these days, all as part of a pitch for Zachary Scheidt’s Contract Income Alert. And they’ve been teased before, but I had a bunch of readers pile on with questions this week — probably thanks to that new “July 22” deadline — so I […]
We’re seeing a lot of questions this week about the promo from Stansberry for Dan Ferris’ Extreme Value (currently $1,499, no refunds), so that’s our focus for today. And it looks like this is a repeat of an ad we’ve looked at a couple times over the past 18 months, but it’s got a new […]
Used a “flatline pattern on a stock chart” to take advantage of dips in the market. Reports sent every two weeks.
Today we have the uncertain pleasure of checking out a teaser pitch from James Altucher, who one of our readers referred to as the “white Don King of the stock gurus” — he’s peddling subscriptions to Altucher’s Investment Network (that’s his “entry level” letter, $79/year), and the bait he dangles out is his “special report” […]
Yesterday I looked into a couple John Malone stocks that were being teased by John DelVecchio’s Hidden Profits, and a question popped up about “the other one” — so I thought I’d check on that for you, too. That ad teased three stocks — two of them were “the billionaire who beats Warren Buffett” ideas, […]
We’ve had questions about this ad pitch from John Del Vecchio over the past few days, and our accounts received a few copies of the ad directly from various sources as well in the past week or so… so I thought we’d look into these “hidden stocks” for you today. But I also looked back […]
I guess this is shaping up to be another “marijuana week” here at Stock Gumshoe… this latest pitch talks up a chance at making five times your money on “a marijuana stock opportunity that almost NO ONE is talking about yet.” Which, of course, is music to our ears — we do love a good […]
This teaser solution was originally published on January 22, 2019, when we first saw the ad running. The ads have still been running in recent weeks, and we’re getting questions about it again, so we’re re-posting it here for your information. The ad has not changed, and my article below has not changed, though the […]
Here’s the lead-in to the ad that caught our readers’ attention this week: “This ‘Perfect Storm’ Stock Is Set to Deliver Big Pharma a Swift and Devastating DEATHBLOW It Won’t Come Back From… “And Launch This Little Company on A 72-Hour, $8.98 Billion All-Out SPRINT” And there’s a deadline… today, in fact, when there will […]
The latest pitch from Marc Lichtenfeld begins with a walking tour of Palm Beach, which is just cruel to those of us enduring mud season in New England, but, more importantly, it also comes with a good ol’ fake deadline of midnight tonight… so I guess I better cover this one quick! Fortunes await! The […]
This pitch about “Federal Rent Checks” has been circulating for quite a while, and it’s still being mailed out with a July 2018 date under the signature (I got a few questions about it just this week), so I decided to take a second look. And what do you know, there has been a LOT […]
Another day, another promise of imminent riches from a biotech clinical trial! This time it’s from Ray Blanco, who has made many such promises in his ads, and the pitch is all about a “bio switch” that has the potential to “end diabetes, plus heart & kidney disease (with a twice-a-day pill).” What more could […]
“For such a beastly month as February, 28 days as a rule are plenty,” said the Pirate King. But you would be surprised at the number of interesting snippets of news in the health-care realm that landed in my inbox during this short month. I’ll lead off with one that gave me a particular kick. […]
I continue to get lots of questions about this Jim Rickards ad from Agora, and the ad itself has been (clumsily) updated a few times since we covered it back in November of 2017 (the latest “by March 19, 2019” ad even suggests that Yellen is still President of the Federal Reserve, and the date […]
Today it’s time for a look at another overheated James Altucher pitch, this time for Altucher’s Top 1% Advisory ($2,000, no refunds) The big idea this time is that he’s teasing a “social media killer” and, of course, “one little company” that he thinks will be the big winner of this “killer” trend. What is […]
This teaser pitch has been around for a few weeks, but I haven’t gotten around to covering it until now… call it marijuana fatigue, just plain laziness, or a surfeit of other hypetastic pitches, but it just didn’t rise to the top. Questions have rolled in from readers pretty consistently, though, so I’m finally digging […]
The latest ad from Ray Blanco has been circulating and generating reader questions for about a week, though I just got it in my own email accounts for the first time yesterday evening… about an hour before the purported “catalyst” was about to come. The ad is from Blanco’s FDA Trader (current $1,499, no refunds). […]
any one know what this [ new ? ] crypto is ? Manward newsletter or something like it ? Says it 100% american not 78% owned like BTC or ETH
Signals for money making opps